We are live on ! Find out more
RCEL icon

Avita Medical

67 hedge funds and large institutions have $16.6M invested in Avita Medical in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $464K | Put options by funds: $74K

3.49% less ownership

Funds ownership: 19.3%15.82% (-3.5%)

12% less funds holding

Funds holding: 7667 (-9)

37% less capital invested

Capital invested by funds: $26.3M → $16.6M (-$9.62M)

52% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 29

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
67
Holders Change
-9
Holders Change %
-11.84%
% of All Funds
0.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
14
Reduced
29
Closed
17
Calls
$464K
Puts
$74K
Net Calls
+$390K
Net Calls Change
-$336K

RCEL Hedge Fund Activity: Q4 2025 in Review

67 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2025, worth a combined $16.6M — down 37% from $26.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of RCEL and 8 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 14 added.

The largest buyer was Geode Capital Management, adding an estimated $589K. The largest seller was HRT Financial, exiting entirely with an estimated $475K sold.

  • 67 institutional investors held Avita Medical (RCEL) as of Q4 2025, down from 76 in Q3 2025.
  • Funds reported $16.6M of Avita Medical stock for Q4 2025, down 37% quarter-over-quarter.
  • 8 funds opened new Avita Medical positions in Q4 2025 and 17 closed out, a net change of -9 holders.
  • The largest Avita Medical buyer in Q4 2025 was Geode Capital Management, an estimated $589K added.
  • The largest Avita Medical seller in Q4 2025 was HRT Financial, an estimated $475K sold.

Based on aggregated 13F filings for Q4 2025.